Home > Insider Trading > Filing (0001209191-21-057517)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1783183	Phathom Pharmaceuticals Inc.	PHAT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1378847	A David Socks	C/O Phathom Pharmaceuticals, Inc. 100 Campus Drive, Suite 102 Florham Pak NJ 07932		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-09-21	13,576	$32.79	1,233,770	No	4	S	Indirect	David A. Socks 2013 Revocable Trust
Common Stock	Disposition	2021-09-21	324	$33.31	1,233,446	No	4	S	Indirect	David A. Socks 2013 Revocable Trust
Common Stock	Disposition	2021-09-22	4,100	$32.06	1,229,346	No	4	S	Indirect	David A. Socks 2013 Revocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	David A. Socks 2013 Revocable Trust
No	4	S	Indirect	David A. Socks 2013 Revocable Trust
No	4	S	Indirect	David A. Socks 2013 Revocable Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	410	Indirect	By 401(k)

Footnotes

All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.20 to $33.1650. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.23 to $33.36. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.66 to $32.57. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.